Works by Ellis, Catherine

Results: 59
    1
    2
    3
    4
    5
    6
    7

    Momelotinib versus Continued Ruxolitinib or Best Available Therapy in JAK Inhibitor-Experienced Patients with Myelofibrosis and Anemia: Subgroup Analysis of SIMPLIFY-2.

    Published in:
    Advances in Therapy, 2024, v. 41, n. 9, p. 3722, doi. 10.1007/s12325-024-02928-4
    By:
    • Harrison, Claire N.;
    • Vannucchi, Alessandro M.;
    • Recher, Christian;
    • Passamonti, Francesco;
    • Gerds, Aaron T.;
    • Hernandez-Boluda, Juan Carlos;
    • Yacoub, Abdulraheem;
    • Sirhan, Shireen;
    • Ellis, Catherine;
    • Patel, Bharat;
    • Strouse, Bryan;
    • Platzbecker, Uwe
    Publication type:
    Article
    8
    9
    10
    11

    Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trial.

    Published in:
    Leukemia & Lymphoma, 2024, v. 65, n. 7, p. 965, doi. 10.1080/10428194.2024.2328800
    By:
    • Gupta, Vikas;
    • Oh, Stephen;
    • Devos, Timothy;
    • Dubruille, Viviane;
    • Catalano, John;
    • Somervaille, Tim C. P.;
    • Platzbecker, Uwe;
    • Giraldo, Pilar;
    • Kosugi, Hiroshi;
    • Sacha, Tomasz;
    • Mayer, Jiri;
    • Illes, Arpad;
    • Ellis, Catherine;
    • Wang, Zhaohui;
    • Gonzalez Carreras, Francisco J.;
    • Strouse, Bryan;
    • Mesa, Ruben
    Publication type:
    Article
    12

    Neuroendocrine neoplasms: Consensus on a patient care pathway.

    Published in:
    Journal of Neuroendocrinology, 2024, v. 36, n. 4, p. 1, doi. 10.1111/jne.13380
    By:
    • Hooper, Jessica;
    • Jervis, Nikie;
    • Morgan, Lucy;
    • Beckett, Vivienne;
    • Hand, Philippa;
    • Higgs, Kate;
    • Munir, Alia;
    • Prinn, Jenny;
    • Pritchard, D Mark;
    • Sarker, Debashis;
    • Srirajaskanthan, Raj;
    • Ellis, Catherine Bouvier
    Publication type:
    Article
    13
    14

    Longitudinal Assessment of Transfusion Intensity in Patients With JAK Inhibitor-Naive or -Experienced Myelofibrosis Treated With Momelotinib.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2025, v. 25, n. 3, p. 199, doi. 10.1016/j.clml.2024.10.001
    By:
    • Harrison, Claire N.;
    • Mesa, Ruben;
    • Talpaz, Moshe;
    • Gupta, Vikas;
    • Gerds, Aaron T.;
    • Perkins, Andrew;
    • Yeow Tee Goh;
    • Fox, Maria Laura;
    • McLornan, Donal;
    • Palmer, Jeanne;
    • Foltz, Lynda;
    • Vannucchi, Alessandro;
    • Koschmieder, Steffen;
    • Passamonti, Francesco;
    • Sung-Eun Lee;
    • Ellis, Catherine;
    • Strouse, Bryan;
    • Gonzalez Carreras, Francisco J.;
    • Oh, Stephen T.
    Publication type:
    Article
    15

    Psychological as well as illness factors influence acceptance of non-invasive ventilation (NIV) and gastrostomy in amyotrophic lateral sclerosis (ALS): A prospective population study.

    Published in:
    Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2014, v. 15, n. 5/6, p. 376, doi. 10.3109/21678421.2014.886700
    By:
    • Martin, Naomi H.;
    • Landau, Sabine;
    • Janssen, Anna;
    • Lyall, Rebecca;
    • Higginson, Irene;
    • Burman, Rachel;
    • McCrone, Paul;
    • Sakel, Mohammed;
    • Ellis, Catherine M.;
    • Shaw, Christopher E.;
    • Al-Chalabi, Ammar;
    • Leigh, P. Nigel;
    • Goldstein, Laura H.
    Publication type:
    Article
    16
    17
    18

    Momelotinib: Mechanism of action, clinical, and translational science.

    Published in:
    CTS: Clinical & Translational Science, 2024, v. 17, n. 8, p. 1, doi. 10.1111/cts.70018
    By:
    • Vlasakakis, Georgios;
    • McCabe, Michael T.;
    • Ho, Yu Liu;
    • Ferron‐Brady, Geraldine;
    • Martin, Paul;
    • Bentley, Darren;
    • Ellis, Catherine;
    • Antonysamy, Mary;
    • Visser, Sandra A. G.
    Publication type:
    Article
    19

    A proposed staging system for amyotrophic lateral sclerosis.

    Published in:
    Brain: A Journal of Neurology, 2012, v. 135, n. 3, p. 847, doi. 10.1093/brain/awr351
    By:
    • Roche, Jose C.;
    • Rojas-Garcia, Ricardo;
    • Scott, Kirsten M.;
    • Scotton, William;
    • Ellis, Catherine E.;
    • Burman, Rachel;
    • Wijesekera, Lokesh;
    • Turner, Martin R.;
    • Leigh, P. Nigel;
    • Shaw, Christopher E.;
    • Al-Chalabi, Ammar
    Publication type:
    Article
    20
    21
    22
    23
    24

    Phase I dose-escalation trial of the oral AKT inhibitor uprosertib in combination with the oral MEK1/MEK2 inhibitor trametinib in patients with solid tumors.

    Published in:
    2020
    By:
    • Tolcher, Anthony W.;
    • Kurzrock, Razelle;
    • Valero, Vincente;
    • Gonzalez, Rene;
    • Heist, Rebecca S.;
    • Tan, Antoinette R.;
    • Means-Powell, Julie;
    • Werner, Theresa L.;
    • Becerra, Carlos;
    • Wang, Chenxi;
    • Leonowens, Cathrine;
    • Kalyana-Sundaram, Shanker;
    • Kleha, Joseph F.;
    • Gauvin, Jennifer;
    • D'Amelio, Anthony M.;
    • Ellis, Catherine;
    • Ibrahim, Nageatte;
    • Yan, Li;
    • D'Amelio, Anthony M Jr
    Publication type:
    journal article
    25

    Orphan G-protein-coupled receptors: the next generation of drug targets?

    Published in:
    British Journal of Pharmacology, 1998, v. 125, n. 7, p. 1387, doi. 10.1038/sj.bjp.0702238
    By:
    • Wilson, Shelagh;
    • Bergsma, Derk J.;
    • Chambers, Jon K.;
    • Muir, Alison I.;
    • Fantom, Kenneth G. M.;
    • Ellis, Catherine;
    • Murdock, Paul R.;
    • Herrity, Nicole C.;
    • Stadel, Jeffrey M.
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.

    Published in:
    Nature, 1999, v. 401, n. 6750, p. 282, doi. 10.1038/45809
    By:
    • Ames, Robert S.;
    • Sarau, Henry M.;
    • Chambers, Johathan K.;
    • Willette, Robert N.;
    • Aiyar, Nambi V.;
    • Romanic, Anne M.;
    • Louden, Calvert S.;
    • Foley, James J.;
    • Sauermelch, Charles F.;
    • Coatney, Robert W.;
    • Ao, Zhaohui;
    • Disa, Jyoti;
    • Holmes, Stephen D.;
    • Stadel, Jeffrey M.;
    • Martin, John D.;
    • Liu, Wu-Schyong;
    • Glover, George I.;
    • Wilson, Shelagh;
    • McNulty, Dean E.;
    • Ellis, Catherine E.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43

    A Phase I, First‐in‐Human Study of GSK2849330, an Anti‐HER3 Monoclonal Antibody, in HER3‐Expressing Solid Tumors.

    Published in:
    Oncologist, 2021, v. 26, n. 10, p. e1844, doi. 10.1002/onco.13860
    By:
    • Gan, Hui K.;
    • Millward, Michael;
    • Jalving, Mathilde;
    • Garrido‐Laguna, Ignacio;
    • Lickliter, Jason D.;
    • Schellens, Jan H.M.;
    • Lolkema, Martijn P.;
    • Van Herpen, Carla L.M.;
    • Hug, Bruce;
    • Tang, Lihua;
    • O'Connor‐Semmes, Robin;
    • Gagnon, Robert;
    • Ellis, Catherine;
    • Ganji, Gopinath;
    • Matheny, Christopher;
    • Drilon, Alexander
    Publication type:
    Article
    44

    Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer.

    Published in:
    Oncologist, 2015, v. 20, n. 9, p. 1001, doi. 10.1634/theoncologist.2015-0138
    By:
    • Guarneri, Valentina;
    • Dieci, Maria Vittoria;
    • Frassoldati, Antonio;
    • Maiorana, Antonino;
    • Ficarra, Guido;
    • Bettelli, Stefania;
    • Tagliafico, Enrico;
    • Bicciato, Silvio;
    • Generali, Daniele Giulio;
    • Cagossi, Katia;
    • Bisagni, Giancarlo;
    • Sarti, Samanta;
    • Musolino, Antonino;
    • Ellis, Catherine;
    • Crescenzo, Rocco;
    • Conte, PierFranco
    Publication type:
    Article
    45
    46
    47
    48

    Efficacy, safety, pharmacokinetics and biomarker findings in patients with HER2-positive advanced or metastatic breast cancer treated with lapatinib in combination with capecitabine: results from 51 Japanese patients treated in a clinical study.

    Published in:
    Breast Cancer (13406868), 2015, v. 22, n. 2, p. 192, doi. 10.1007/s12282-013-0475-1
    By:
    • Iwata, Hiroji;
    • Fujii, Hirofumi;
    • Masuda, Norikazu;
    • Mukai, Hirofumi;
    • Nishimura, Yuichiro;
    • Katsura, Koichi;
    • Ellis, Catherine;
    • Gagnon, Robert;
    • Nakamura, Seigo
    Publication type:
    Article
    49
    50